Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Evaluate crypto assets based on use case, supply dynamics, and market liquidity to guide beginner-friendly buying decisions for 2024.
26,888 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
AI infrastructure names rebounded on Wednesday, led by Terawulf and IREN as risk appetite returns to tech equities. A...
Gold miners ETFs are in focus as 2026's rally tests the resilience of senior producers versus junior explorers. This ...
A legendary production designer reshaped 1969 Los Angeles for a Tarantino film, and her approach offers practical mon...
A Tuesday rally put Tower Semiconductor in the spotlight as investors priced in capacity upgrades and stronger demand...
Fairway Home Mortgage launches a nonprofit arm to combat elder financial fraud, unveiling Fairway SAFE with free educ...
Rocket Lab shares hover near $67 as July odds tilt toward downside. This story breaks down what prediction markets be...
A single quantum computing stock could reshape your portfolio like Palantir did for AI software. This guide breaks do...
Accelerant Holdings has fallen sharply since its IPO, but a major fund just took a sizable stake. This article explai...
Park Hotels 2025 earnings data in Q4 reveals how occupancy, pricing, and balance-sheet moves drive the next leg of th...
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
SoundHound AI is testing a high-growth path in voice commerce and Vision AI. This article explains why some investors...